Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Ilmarinen (Seinäjoki, Finland), L. Tuomisto (Seinäjoki, Finland), O. Niemelä (Seinäjoki, Finland), H. Kankaanranta (Seinäjoki and Tampere, Finland). Patients eligible for anti-IL-5/anti-IL-5Ra treatment in a cohort of adult-onset asthma. 1130

Member's Comments

No comment yet.

Related content which might interest you: Osteoporosis onset in patients prescribed ICS for COPD: matched cohort study Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Patients at risk for COPD compared to patients diagnosed with COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 A longitudinal follow-up of severe asthma patients receiving reslizumab Source: International Congress 2017 – Asthma management Year: 2017 Depressive symptoms among patients with chronic obstructive pulmonary disease before and after smoking cessation – a Danish nationwide cohort study of 21 184 patients Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Treatment eligibility of mepolizumab-treated severe asthma patients in clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Frequency and impact of bronchiectasis in a cohort of patients in a COPD clinic Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Re-evaluation of asthma diagnosis in patients with adult-onset asthma Source: International Congress 2017 – New research in asthma and COPD Year: 2017 Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study Source: Eur Respir J, 55 (2) 1901335; 10.1183/13993003.01335-2019 Year: 2020 “App” for uncontrolled moderate-severe asthma patients follow-up Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Effect of omalizumab on the risk of hospitalisation in patients with uncontrolled severe asthma in real-life. The PAX-LASER cohort Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Prognosis of COPD according to exacerbation history: a population-based cohort study Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study Source: Eur Respir J, 54 (5) 1900804; 10.1183/13993003.00804-2019 Year: 2019 Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers Year: 2018 Long-term prognosis of new adult-onset asthma in obese patients Source: Eur Respir J, 57 (4) 2001209; 10.1183/13993003.01209-2020 Year: 2021 Two therapy option in patients with uncontrolled asthma Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Efficacy of ruzam in the treatment of patients with mild-to-moderate asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Population-based case-finding to identify subjects with undiagnosed asthma or COPD Source: Eur Respir J, 55 (6) 2000024; 10.1183/13993003.00024-2020 Year: 2020 Anti-inflammatory asthma therapy adherence in paediatric patients: The PACMAN cohort study Source: Annual Congress 2010 - Management of airway disease Year: 2010